Form 4: TransMedics Group CEO Waleed Hassanein Exercises and Sells Stock Options

CEO Waleed Hassanein exercised stock options and sold shares of TransMedics Group, Inc. on August 21 and 22, 2024.

Summary

• Waleed H. Hassanein, the President and CEO of TransMedics Group, Inc., engaged in transactions involving the company's stock on August 21 and 22, 2024.
• On August 21, 2024, Hassanein exercised options to acquire 20,000 shares of common stock at a price of $16 per share and then sold those 20,000 shares at a weighted average price of $171.03.
• On August 22, 2024, Hassanein exercised options to acquire 25,000 shares of common stock at a price of $16.14 per share and then sold those 25,000 shares at a price of $175.
• Following these transactions, Hassanein directly owns 61,643 shares of common stock and indirectly owns 469,359 shares through the Waleed H. Hassanein Revocable Trust.
• Hassanein also directly owns options to purchase 265,714 and 153,000 shares of common stock at exercise prices of $16 and $16.14 respectively.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's future prospects.

Industry Context

This filing is a routine disclosure of insider transactions. It's common for executives to exercise stock options and sell shares for personal financial management.

Key Dates